BDULF
Price
$0.63
Change
+$0.01 (+1.61%)
Updated
Sep 3 closing price
Capitalization
9.67B
Intraday Buy/Sell Signals
GBCS
Price
$1.70
Change
-$0.30 (-15.00%)
Updated
Oct 17 closing price
Capitalization
5.21M
Intraday Buy/Sell Signals
Interact to see
Advertisement

BDULF vs GBCS

Header iconBDULF vs GBCS Comparison
Open Charts BDULF vs GBCSBanner chart's image
Bangkok Dusit Medical Services Public
Price$0.63
Change+$0.01 (+1.61%)
Volume$155
Capitalization9.67B
Selectis Health
Price$1.70
Change-$0.30 (-15.00%)
Volume$32.72K
Capitalization5.21M
BDULF vs GBCS Comparison Chart in %
BDULF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDULF vs. GBCS commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDULF is a Hold and GBCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (BDULF: $0.63 vs. GBCS: $1.70)
Brand notoriety: BDULF and GBCS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: BDULF: 31% vs. GBCS: 355%
Market capitalization -- BDULF: $9.67B vs. GBCS: $5.21M
BDULF [@Hospital/Nursing Management] is valued at $9.67B. GBCS’s [@Hospital/Nursing Management] market capitalization is $5.21M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $99.72B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDULF’s FA Score shows that 1 FA rating(s) are green whileGBCS’s FA Score has 1 green FA rating(s).

  • BDULF’s FA Score: 1 green, 4 red.
  • GBCS’s FA Score: 1 green, 4 red.
According to our system of comparison, BDULF is a better buy in the long-term than GBCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDULF’s TA Score shows that 0 TA indicator(s) are bullish while GBCS’s TA Score has 3 bullish TA indicator(s).

  • BDULF’s TA Score: 0 bullish, 1 bearish.
  • GBCS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BDULF is a better buy in the short-term than GBCS.

Price Growth

BDULF (@Hospital/Nursing Management) experienced а 0.00% price change this week, while GBCS (@Hospital/Nursing Management) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.23%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was +14.46%.

Industries' Descriptions

@Hospital/Nursing Management (+0.23% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDULF($9.67B) has a higher market cap than GBCS($5.21M). GBCS YTD gains are higher at: 51.786 vs. BDULF (-25.767). BDULF has higher annual earnings (EBITDA): 27.7B vs. GBCS (-85.47K). BDULF has more cash in the bank: 6.74B vs. GBCS (560K). GBCS has less debt than BDULF: GBCS (31.6M) vs BDULF (16.4B). BDULF has higher revenues than GBCS: BDULF (110B) vs GBCS (41.3M).
BDULFGBCSBDULF / GBCS
Capitalization9.67B5.21M185,462%
EBITDA27.7B-85.47K-32,408,274%
Gain YTD-25.76751.786-50%
P/E Ratio19.96N/A-
Revenue110B41.3M266,344%
Total Cash6.74B560K1,202,679%
Total Debt16.4B31.6M51,899%
FUNDAMENTALS RATINGS
BDULF vs GBCS: Fundamental Ratings
BDULF
GBCS
OUTLOOK RATING
1..100
3587
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
74
Overvalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
51100
PRICE GROWTH RATING
1..100
6062
P/E GROWTH RATING
1..100
8616
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDULF's Valuation (9) in the null industry is somewhat better than the same rating for GBCS (74). This means that BDULF’s stock grew somewhat faster than GBCS’s over the last 12 months.

GBCS's Profit vs Risk Rating (96) in the null industry is in the same range as BDULF (100). This means that GBCS’s stock grew similarly to BDULF’s over the last 12 months.

BDULF's SMR Rating (51) in the null industry is somewhat better than the same rating for GBCS (100). This means that BDULF’s stock grew somewhat faster than GBCS’s over the last 12 months.

BDULF's Price Growth Rating (60) in the null industry is in the same range as GBCS (62). This means that BDULF’s stock grew similarly to GBCS’s over the last 12 months.

GBCS's P/E Growth Rating (16) in the null industry is significantly better than the same rating for BDULF (86). This means that GBCS’s stock grew significantly faster than BDULF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDULFGBCS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
25%
Bearish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
21%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
14%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BDULF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTKG1.500.03
+2.04%
X3 Holdings Co Ltd
TPR116.820.31
+0.27%
Tapestry
JBSS61.16-0.14
-0.23%
John B Sanfilippo & Son
CGON41.46-0.39
-0.93%
CG Oncology
FLGC18.00-1.00
-5.29%
Flora Growth Corp

BDULF and

Correlation & Price change

A.I.dvisor tells us that BDULF and MD have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDULF and MD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDULF
1D Price
Change %
BDULF100%
N/A
MD - BDULF
8%
Poorly correlated
+1.54%
PIII - BDULF
8%
Poorly correlated
-3.67%
NUMIF - BDULF
7%
Poorly correlated
-4.29%
RHEP - BDULF
6%
Poorly correlated
+9.49%
INNV - BDULF
5%
Poorly correlated
-3.00%
More

GBCS and

Correlation & Price change

A.I.dvisor tells us that GBCS and PIII have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GBCS and PIII's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBCS
1D Price
Change %
GBCS100%
-15.00%
PIII - GBCS
10%
Poorly correlated
-3.67%
PHCI - GBCS
2%
Poorly correlated
-2.94%
AIRS - GBCS
2%
Poorly correlated
-3.90%
DCGO - GBCS
2%
Poorly correlated
-4.92%
BDULF - GBCS
1%
Poorly correlated
N/A
More